Royalty Pharma (RPRX) News Today $30.75 -0.20 (-0.65%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Overbrook Management Corp Has $3.02 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Overbrook Management Corp lessened its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 16.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 118,408 shares of the biopharmaceutical company's stock after selling 22,500 shares during theJanuary 20 at 9:02 AM | marketbeat.comRoyalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks NowJanuary 16, 2025 | msn.comRoyalty Pharma: Key Strategic Updates To Be Priced InJanuary 15, 2025 | seekingalpha.comRoyalty Pharma Target of Unusually Large Options Trading (NASDAQ:RPRX)Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors purchased 2,751 call options on the stock. This represents an increase of 532% compared to the average daily volume of 435 call options.January 14, 2025 | marketbeat.comRoyalty Pharma’s Strategic Acquisition and Share Buyback Boosts Growth OutlookJanuary 14, 2025 | markets.businessinsider.comPallas Capital Advisors LLC Invests $2.36 Million in Royalty Pharma plc (NASDAQ:RPRX)Pallas Capital Advisors LLC purchased a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 92,334 shares of the biopharmaceutical company's stock, valued atJanuary 13, 2025 | marketbeat.comNordea Investment Management AB Lowers Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Nordea Investment Management AB cut its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 95.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,793 shares of the biopharmaceutJanuary 13, 2025 | marketbeat.comHere’s Why Royalty Pharma plc (RPRX) Led This Week’s RallyJanuary 12, 2025 | msn.comRoyalty Pharma plc (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from BrokeragesRoyalty Pharma plc (NASDAQ:RPRX - Get Free Report) has been given a consensus recommendation of "Buy" by the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and oJanuary 12, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Shares Gap Up After Dividend AnnouncementJanuary 12, 2025 | americanbankingnews.comDid Royalty Pharma (RPRX) Close Shortened Trading Week Higher?January 11, 2025 | msn.comRoyalty Pharma increases quarterly dividend 5% to 22c per shareJanuary 10, 2025 | markets.businessinsider.comRoyalty Pharma plc (NASDAQ:RPRX) Raises Dividend to $0.22 Per ShareRoyalty Pharma plc (NASDAQ:RPRX) announced a quarterly dividend on Friday, January 10th. Shareholders of record on Friday, February 21st will be given a dividend of 0.22 per share by the biopharmaceutical company on Monday, March 10th. This represents a $0.88 annualized dividend and a yield of 2.98%. The ex-dividend date of this dividend is Friday, February 21st. This is a boost from Royalty Pharma's previous quarterly dividend of $0.21.January 10, 2025 | marketbeat.comRoyalty Pharma sees FY24 revenue $2.8B, consensus $2.65BJanuary 10, 2025 | markets.businessinsider.comRoyalty Pharma announces two steps to increase shareholder valueJanuary 10, 2025 | markets.businessinsider.comRoyalty Pharma increases quarterly dividend 5% to 22c per Class A shareJanuary 10, 2025 | markets.businessinsider.comRoyalty Pharma (NASDAQ:RPRX) Shares Gap Up - Here's What HappenedRoyalty Pharma (NASDAQ:RPRX) Shares Gap Up - Here's What HappenedJanuary 10, 2025 | marketbeat.comRoyalty Pharma simplifies corporate structure with $1.1 bln dealJanuary 10, 2025 | reuters.comRoyalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 10, 2025 | globenewswire.comRoyalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase ProgramJanuary 10, 2025 | globenewswire.comRoyalty Pharma Announces Dividend IncreaseJanuary 9, 2025 | globenewswire.comJPMorgan Chase & Co. Sells 6,449,863 Shares of Royalty Pharma plc (NASDAQ:RPRX)JPMorgan Chase & Co. reduced its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 83.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,289,418 shares of the biopharmaceutical company's stockJanuary 7, 2025 | marketbeat.comJim Cramer on Royalty Pharma plc (RPRX): ‘Disappointing Stock, Man, I Can’t Believe It’December 27, 2024 | insidermonkey.comRoyalty Pharma (RPRX) Gets a Buy from TD CowenDecember 25, 2024 | markets.businessinsider.comRoyalty Pharma (NASDAQ:RPRX) Rating Increased to Strong-Buy at TD CowenTD Cowen raised shares of Royalty Pharma to a "strong-buy" rating in a research report on Tuesday.December 25, 2024 | marketbeat.comJim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’December 24, 2024 | insidermonkey.comRoyalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the companyDecember 24, 2024 | finance.yahoo.comJim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’December 24, 2024 | msn.comRoyalty Pharma (NASDAQ:RPRX) Sees Strong Trading Volume - Should You Buy?Royalty Pharma (NASDAQ:RPRX) Sees Large Volume Increase - Here's What HappenedDecember 23, 2024 | marketbeat.comWellington Management Group LLP Sells 39,598 Shares of Royalty Pharma plc (NASDAQ:RPRX)Wellington Management Group LLP lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 69.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,806 shares of the biopharmaceuticDecember 21, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Bought by Franklin Resources Inc.Franklin Resources Inc. boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,460,515 shares of the biopharmaceutical comDecember 18, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of "Moderate Buy" by AnalystsRoyalty Pharma plc (NASDAQ:RPRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the comDecember 18, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Barclays PLCBarclays PLC increased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 16.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 308,887 shares of the biopharmaceutical company's stock after acquirDecember 18, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low - What's Next?Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month Low - Time to Sell?December 17, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Geode Capital Management LLCGeode Capital Management LLC raised its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,265,786 shares of the biopharmaceutical company's stocDecember 16, 2024 | marketbeat.comSynovus Financial Corp Trims Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Synovus Financial Corp lessened its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 53.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 104,297 shares of the biopharmaceutical company's stock after selDecember 15, 2024 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Stock, Insider Trading ActivityDecember 14, 2024 | benzinga.com3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or LongerDecember 13, 2024 | fool.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by State Street CorpState Street Corp grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 0.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,516,262 shares of the biopharmDecember 11, 2024 | marketbeat.comExecutive Wealth Management LLC Has $2.11 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Executive Wealth Management LLC trimmed its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 23.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 74,700 shares of the biopharmaceutical company's stock after seDecember 10, 2024 | marketbeat.comKovitz Investment Group Partners LLC Decreases Stake in Royalty Pharma plc (NASDAQ:RPRX)Kovitz Investment Group Partners LLC reduced its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 29.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 118,75December 9, 2024 | marketbeat.com526,633 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 526,633 shares of the biopharmaceutical company's stock, valued at approDecember 7, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Sells 127,825 Shares of Royalty Pharma plc (NASDAQ:RPRX)The Manufacturers Life Insurance Company decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 45.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 152,027 shares of the biopharmaceutical company's stock after sellDecember 7, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Two Sigma Advisers LPTwo Sigma Advisers LP boosted its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 44.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,033,200 shares of the biopharmaceutical company's stock aDecember 6, 2024 | marketbeat.comPoint72 DIFC Ltd Invests $1.86 Million in Royalty Pharma plc (NASDAQ:RPRX)Point72 DIFC Ltd bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 65,861 shares of the biopharmaceutical company's stock, valued at approximately $1,863,000. Several other institutionalDecember 5, 2024 | marketbeat.comIs Royalty Pharma (RPRX) the Best All-Time Low Stock to Buy Right Now?December 4, 2024 | insidermonkey.com2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the DipsDecember 4, 2024 | fool.comArrowMark Colorado Holdings LLC Makes New $2.03 Million Investment in Royalty Pharma plc (NASDAQ:RPRX)ArrowMark Colorado Holdings LLC bought a new stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 71,750 shares of the biopharmaceutical company's sDecember 3, 2024 | marketbeat.comPDT Partners LLC Sells 20,502 Shares of Royalty Pharma plc (NASDAQ:RPRX)PDT Partners LLC reduced its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 39.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,934 shares of the biopharmaceutical company's stock afterDecember 3, 2024 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 6.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,972,201 shares ofDecember 3, 2024 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼1.160.60▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼66▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RPRX Stock Alerts